The Effect of Rifampicin on the Plasma Pharmacokinetics of Emtricitabine (FTC) and Tenofovir Alafenamide Fumarate (TAF) and Intracellular Tenofovir-diphosphate (TFV-DP) and FTC-triphosphate (FTC-TP)
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Oct 2017
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary) ; Rifampicin (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms RIFT
- 23 Oct 2017 Planned End Date changed from 30 Sep 2017 to 15 Dec 2017.
- 23 Oct 2017 Planned primary completion date changed from 30 Sep 2017 to 15 Dec 2017.
- 23 Oct 2017 Status changed from recruiting to active, no longer recruiting.